Ashlee D Brunaugh

Years Active: 2017-2022
Publications (10 Years): 5

University of Texas System (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Texas System Aug 26 2016

United States

PHD :: Molecular Pharmaceutics and Drug Delivery

Publications

Ashlee D Brunaugh, Amanda Walz, Zachary Warnken, Camron Pearce, Juan Munoz Gutierrez, John J Koleng, Hugh D C Smyth, Mercedes Gonzalez-Juarrero
Respirable Clofazimine Particles Produced by Air Jet Milling Technique Are Efficacious in Treatment of BALB/c Mice with Chronic Mycobacterium tuberculosis Infection. Antimicrobial agents and chemotherapy 66 (9) (2022)
Ashlee D Brunaugh, Shivam Sharma, Hugh D C Smyth
Inhaled fixed-dose combination powders for the treatment of respiratory infections. Expert opinion on drug delivery 18 (8) (2021)
Ashlee D Brunaugh, Hyojong Seo, Zachary Warnken, Li Ding, Sang Heui Seo, Hugh D C Smyth
Development and evaluation of inhalable composite niclosamide-lysozyme particles: A broad-spectrum, patient-adaptable treatment for coronavirus infections and sequalae. PloS one 16 (2) (2021)
Ashlee D Brunaugh, Tian Wu, Sekhar R Kanapuram, Hugh D C Smyth
Effect of Particle Formation Process on Characteristics and Aerosol Performance of Respirable Protein Powders. Molecular pharmaceutics 16 (10) (2019)
Ashlee D Brunaugh, Syed Umer Jan, Silvia Ferrati, Hugh D C Smyth
Excipient-Free Pulmonary Delivery and Macrophage Targeting of Clofazimine via Air Jet Micronization. Molecular pharmaceutics 14 (11) (2017)

Ashlee D Brunaugh.css-eqlu8i{font-size:small;padding-left:4px;}